, Volume 178, Issue 3–4, pp 273–278 | Cite as

Cutaneous and Bone Marrow Histoplasmosis After 18 Years of Renal Allograft Transplant

  • K. Y. Ibrahim
  • N. B. Carvalho
  • E. V. Mimicos
  • H. Yeh-Li
  • M. N. Sotto
  • F. O. S. França


The frequency of histoplasmosis among solid organ transplant (SOT) recipients appears to be low where there are only a few case series, mostly among renal and liver transplant recipients. Herein we report a case of a 44-year-old woman who underwent a living-related renal transplant 18 years prior to evaluation, developed a nodule after followed by ulceration upon her posterior right leg and a second one upon her left leg 3 months and 2 months before her hospitalisation, respectively. The biopsy of lesion revealed the presence of Histoplasma spp. Bone marrow aspiration was performed and also revealed the same organism. She had initially received itraconazole without improvement of lesions, while a new lesion appeared on her left arm. Healing of all lesions could be observed after 40 days of liposomal amphotericin B when she was submitted to skin grafts on the legs and a surgical treatment on the arms, and the myelosuppression improved simultaneously. Histoplasmosis seems to be very uncommon among patients who underwent to organ solid transplantation. Most cases occur within 12–18 months after transplantation, although unusual cases have been presented many years post-transplant. There are cases reported in the literature, occurring from 84 days to 18 years after organ transplantation, but without cutaneous involvement. Our patient developed lesions on limbs and myelosuppression after 18 years of chronic immunosuppression medication. This case suggests that besides cutaneous histoplasmosis is an uncommon infection following iatrogenic immunosuppression and even rarer over a long period after the transplantation. Clinicians who care SOT recipient patients must bear in mind histoplasmosis infection as differential diagnosis in any case of cutaneous injury with prolonged fever and try to use as many tools as possible to make the diagnosis, once this disease presents a good prognosis if it is diagnosed and treated promptly.


Histoplasmosis Transplantation Infection Renal allograft 


Conflict of interest

The authors report no conflict of interests.


  1. 1.
    Cuellar-Rodriguez J, Avery RK, Lard M, Budev M, et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis. 2009;49:710–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Koo HL, Hamill RJ, Gentry LO. Disseminated histoplasmosis manifesting as a soft-tissue chest wall mass in a heart transplant recipient. Transpl Infect Dis. 2008;10:351–3.PubMedCrossRefGoogle Scholar
  3. 3.
    Shah SS, Karnak D, Shah SN, et al. Broncholith caused by donor acquired histoplasmosis in a lung transplant recipient. J Heart Lung Tranplant. 2007;26:407–10.CrossRefGoogle Scholar
  4. 4.
    Vail GM, Young RS, Wheat LJ, Filo RS, Cornetta K, Goldman M. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis. 2002;4:148–51.PubMedCrossRefGoogle Scholar
  5. 5.
    Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Histoplasmosis in solid organ transplant recipients at a large midwestern university transplant center. Transpl Infect Dis. 2005;7:109–15.PubMedCrossRefGoogle Scholar
  6. 6.
    Peddi VR, Hariharan S, First MR. Disseminated histoplasmosis in renal allograft recipients. Clin Transplant. 1996;10:160–5.PubMedGoogle Scholar
  7. 7.
    Marques SA, Hozumi S, Camargo RMP, Carvalho MFC, Marques MEA. Histoplasmosis presenting as cellulitis 18 years after renal transplantation. Med Mycol. 2008;46:725–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Freifeld AG, Wheat LJ, Kaul DR. Histoplasmosis in solid organ transplant recipients: early diagnosis and treatment. Curr Opin Organ Transplant. 2009;14:601–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Wheat LJ, Slama TG, Norton JA, et al. Risk factors for disseminated or fatal histoplasmosis. Ann Intern Med. 1982;96:159–63.PubMedCrossRefGoogle Scholar
  10. 10.
    Kauffman CA, Israel KE, Smith JW, et al. Histoplasmosis in immunosuppressed patients. Am J Med. 1978;64:923–32.PubMedCrossRefGoogle Scholar
  11. 11.
    Wheat J. Histoplasmosis in the acquired immunodeficiency syndrome. Curr Top Med Mycol. 1996;7:7–18.PubMedGoogle Scholar
  12. 12.
    Limaye AP, Connolly PA, Sagar M, et al. Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med. 2000;343:1163–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Wheat J, MaWhinney S, Hafner R, et al. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. Am J Med. 1997;103:223–32.PubMedCrossRefGoogle Scholar
  14. 14.
    Sridhar NR, Tchervenkov JI, Weiss MA, et al. Disseminated histoplasmosis in a renal transplant patient: a cause of renal failure several years following transplantation. Am J Kidney Dis. 1991;17:719–21.PubMedCrossRefGoogle Scholar
  15. 15.
    Motta ACF, Galo R, Lourenço AG, et al. Unusual orofacial manifestation of histoplasmosis in renal transplanted patient. Mycopathologia. 2006;161:161–5.PubMedCrossRefGoogle Scholar
  16. 16.
    McGuinn ML, Lawrence LP, Segreti J. Progressive disseminated histoplasmosis presenting as cellulitis in a renal transplant recipient. J Transplant Proc. 2005;37:4313–4.CrossRefGoogle Scholar
  17. 17.
    Delfino VDA, Matni AM, Gordan PA, Mocelin AJ. Micoses profundas em transplantados renais: indicação de alerta clinico. J Bras Nefrol. 1994;16:143–8.Google Scholar
  18. 18.
    Rosado-Odom VM, Daoud J, Johnson R, et al. Cutaneous presentation of progressive disseminated histoplasmosis nine years after renal transplantation. Transpl Infect Dis. 2013;15:E64–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Masri K, Mahon N, Rosario A, et al. Reactive hemophagocytic syndrome associated with disseminated histoplasmosis in a heart transplant recipient. J Heart Lung Transplant. 2003;22:487–91.PubMedCrossRefGoogle Scholar
  20. 20.
    Mesa H, Pambuccian S, Ferrieri P, Brunning R. A case of systemic histoplasmosis diagnosed in a peripheral blood smear. Br J Haematol. 2004;127:241.PubMedCrossRefGoogle Scholar
  21. 21.
    Kauffman CA. Histoplasmosis: a clinical and laboratorial update. Clin Microbiol Rev. 2007;20:115–32.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guideline for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:807–25.PubMedCrossRefGoogle Scholar
  23. 23.
    Flannery MT, Chapman V, Cruz-Gonzales I, Rivera M, Messina JL. Ileal perforation secondary to histoplasmosis in AIDS. Am J Med Sci. 2000;320:406–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  • K. Y. Ibrahim
    • 1
  • N. B. Carvalho
    • 1
  • E. V. Mimicos
    • 1
  • H. Yeh-Li
    • 1
  • M. N. Sotto
    • 3
  • F. O. S. França
    • 2
  1. 1.Division of Infectious and Parasitic Diseases, Hospital das Clínicas, School of MedicineUniversity of São PauloSão PauloBrazil
  2. 2.Department of Infectious and Parasitic Diseases, School of MedicineUniversity of São PauloSão PauloBrazil
  3. 3.Department of Pathology and Head of Dermatopathology Laboratory, School of MedicineUniversity of São PauloSão PauloBrazil

Personalised recommendations